196 related articles for article (PubMed ID: 33295289)
1. Hydroxychloroquine and Remdesivir in COVID-19: A critical analysis of recent events.
Dang A; Vallish BN; Dang S
Indian J Med Ethics; 2020; V(3):202-207. PubMed ID: 33295289
[TBL] [Abstract][Full Text] [Related]
2. Use of Hydroxychloroquine, Remdesivir, and Dexamethasone Among Adults Hospitalized With COVID-19 in the United States : A Retrospective Cohort Study.
Mehta HB; An H; Andersen KM; Mansour O; Madhira V; Rashidi ES; Bates B; Setoguchi S; Joseph C; Kocis PT; Moffitt R; Bennett TD; Chute CG; Garibaldi BT; Alexander GC;
Ann Intern Med; 2021 Oct; 174(10):1395-1403. PubMed ID: 34399060
[TBL] [Abstract][Full Text] [Related]
3. Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
; Pan H; Peto R; Henao-Restrepo AM; Preziosi MP; Sathiyamoorthy V; Abdool Karim Q; Alejandria MM; Hernández García C; Kieny MP; Malekzadeh R; Murthy S; Reddy KS; Roses Periago M; Abi Hanna P; Ader F; Al-Bader AM; Alhasawi A; Allum E; Alotaibi A; Alvarez-Moreno CA; Appadoo S; Asiri A; Aukrust P; Barratt-Due A; Bellani S; Branca M; Cappel-Porter HBC; Cerrato N; Chow TS; Como N; Eustace J; García PJ; Godbole S; Gotuzzo E; Griskevicius L; Hamra R; Hassan M; Hassany M; Hutton D; Irmansyah I; Jancoriene L; Kirwan J; Kumar S; Lennon P; Lopardo G; Lydon P; Magrini N; Maguire T; Manevska S; Manuel O; McGinty S; Medina MT; Mesa Rubio ML; Miranda-Montoya MC; Nel J; Nunes EP; Perola M; Portolés A; Rasmin MR; Raza A; Rees H; Reges PPS; Rogers CA; Salami K; Salvadori MI; Sinani N; Sterne JAC; Stevanovikj M; Tacconelli E; Tikkinen KAO; Trelle S; Zaid H; Røttingen JA; Swaminathan S
N Engl J Med; 2021 Feb; 384(6):497-511. PubMed ID: 33264556
[TBL] [Abstract][Full Text] [Related]
4. Synergistic and Antagonistic Drug Combinations against SARS-CoV-2.
Bobrowski T; Chen L; Eastman RT; Itkin Z; Shinn P; Chen CZ; Guo H; Zheng W; Michael S; Simeonov A; Hall MD; Zakharov AV; Muratov EN
Mol Ther; 2021 Feb; 29(2):873-885. PubMed ID: 33333292
[TBL] [Abstract][Full Text] [Related]
5. Remdesivir: Critical Clinical Appraisal for COVID 19 Treatment.
Chatterjee S
Drug Res (Stuttg); 2021 Mar; 71(3):138-148. PubMed ID: 33124007
[TBL] [Abstract][Full Text] [Related]
6. Remdesivir: treatment of COVID-19 in special populations.
Molaei E; Molaei A; Hayes AW; Karimi G
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):3829-3855. PubMed ID: 38180557
[TBL] [Abstract][Full Text] [Related]
7. Retrospective evaluation of seven different treatment protocols in hospitalized COVID-19 patients.
Demir Önder K; Seremet Keskin A; Berk H; Seyman D; Öztoprak N
Turk J Med Sci; 2021 Dec; 51(6):2835-2849. PubMed ID: 34418000
[TBL] [Abstract][Full Text] [Related]
8. Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses.
WHO Solidarity Trial Consortium
Lancet; 2022 May; 399(10339):1941-1953. PubMed ID: 35512728
[TBL] [Abstract][Full Text] [Related]
9. Rapid review of suspected adverse drug events due to remdesivir in the WHO database; findings and implications.
Charan J; Kaur RJ; Bhardwaj P; Haque M; Sharma P; Misra S; Godman B
Expert Rev Clin Pharmacol; 2021 Jan; 14(1):95-103. PubMed ID: 33252992
[No Abstract] [Full Text] [Related]
10. Real life experience on the use of Remdesivir in patients admitted to COVID-19 in two referral Italian hospital: a propensity score matched analysis.
Veronese N; Di Gennaro F; Frallonardo L; Ciriminna S; Papagni R; Carruba L; Agnello D; De Iaco G; De Gennaro N; Di Franco G; Naro L; Brindicci G; Rizzo A; Bavaro DF; Garlisi MC; Santoro CR; Signorile F; Balena F; Mansueto P; Milano E; Giannitrapani L; Fiordelisi D; Mariani MF; Procopio A; Lattanzio R; Licata A; Vernuccio L; Amodeo S; Guido G; Segala FV; Barbagallo M; Saracino A
Sci Rep; 2024 Apr; 14(1):9303. PubMed ID: 38654033
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes and safety of remdesivir in hospitalized individuals with COVID-19, with or without severe renal impairment.
Chang MC; Wu PF; Ho YC; Lin WY; Wu CY; Liu SY; Liu CJ; Lin YT
J Infect Public Health; 2024 Jul; 17(7):102460. PubMed ID: 38820894
[TBL] [Abstract][Full Text] [Related]
12. Antiviral Use in Mild-to-Moderate SARS-CoV-2 Infections during the Omicron Wave in Geriatric Patients.
Exquis N; Dionisi B; Samer CF; Rollason V; Curtin F; Zekry D; Graf C; Prendki V; Ing Lorenzini K
Viruses; 2024 May; 16(6):. PubMed ID: 38932157
[TBL] [Abstract][Full Text] [Related]
13. Remdesivir: A potential game-changer or just a myth? A systematic review and meta-analysis.
Shrestha DB; Budhathoki P; Syed NI; Rawal E; Raut S; Khadka S
Life Sci; 2021 Jan; 264():118663. PubMed ID: 33121991
[TBL] [Abstract][Full Text] [Related]
14. Safety and effectiveness of remdesivir in hospitalized patients with COVID-19 and severe renal impairment: experience at a large medical center.
Chang HY; Hsu CC; Hu LF; Chou CY; Chang YL; Lu CC; Chang LJ
Ann Med; 2024 Dec; 56(1):2361843. PubMed ID: 38830017
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of the early treatment with tocilizumab-hydroxychloroquine and tocilizumab-remdesivir in severe COVID-19 Patients.
Sarhan RM; Harb HS; Abou Warda AE; Salem-Bekhit MM; Shakeel F; Alzahrani SA; Madney YM; Boshra MS
J Infect Public Health; 2022 Jan; 15(1):116-122. PubMed ID: 34764044
[TBL] [Abstract][Full Text] [Related]
16. A Perspective on Emerging Therapeutic Interventions for COVID-19.
Torequl Islam M; Nasiruddin M; Khan IN; Mishra SK; Kudrat-E-Zahan M; Alam Riaz T; Ali ES; Rahman MS; Mubarak MS; Martorell M; Cho WC; Calina D; Docea AO; Sharifi-Rad J
Front Public Health; 2020; 8():281. PubMed ID: 32733837
[TBL] [Abstract][Full Text] [Related]
17. What we have learned from the COVID-19 pandemic: Time to think outside the box, maybe far outside.
Lambert WC; Alhatem A; Lambert MW; Schwartz RA
Clin Dermatol; 2021; 39(1):107-117. PubMed ID: 33972037
[TBL] [Abstract][Full Text] [Related]
18. Antimalarial and cytotoxic drugs on COVID-19 and the cardiovascular burden: Literature review and lessons to be learned.
Sultan S; Acharya Y
Vascular; 2021 Apr; 29(2):220-227. PubMed ID: 32691699
[TBL] [Abstract][Full Text] [Related]
19. Dynamic diversity of SARS-CoV-2 genetic mutations in a lung transplantation patient with persistent COVID-19.
Igari H; Sakao S; Ishige T; Saito K; Murata S; Yahaba M; Taniguchi T; Suganami A; Matsushita K; Tamura Y; Suzuki T; Ido E
Nat Commun; 2024 Apr; 15(1):3604. PubMed ID: 38684722
[TBL] [Abstract][Full Text] [Related]
20. Response to Özdemir Ö on "Kounis syndrome due to remdesivir allergy".
Beneki E; Dimitriadis K; Antonopoulos A; Aggeli K; Tsioufis K
Clin Toxicol (Phila); 2024 Apr; 62(4):275-276. PubMed ID: 38639134
[No Abstract] [Full Text] [Related]
[Next] [New Search]
